CoChat

Effects of Antibiotic Therapy in Primary Sclerosing Cholangitis with and without Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

Open access
Shah, Ayesha, Crawford, Darrel, Burger, Daniel, Martin, Neal, Walker, Marjorie, Talley, Nicholas J., Tallis, Caroline, Jones, Michael, Stuart, Katherine, Keely, Simon, Lewindon, Peter, Macdonald, Graeme A., Morrison, Mark, Holtmann, Gerald J. · 2019 · Seminars in Liver Disease
Cited by 81

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

The authors conducted a systematic review and meta-analysis to assess the effect of antibiotic therapy in primary sclerosing cholangitis (PSC). Effect of antibiotic therapy on Mayo PSC Risk Score (MRS), serum alkaline phosphatase (ALP), total serum bilirubin (TSB), and adverse events (AEs) rates were calculated and expressed as standardized difference of means or proportions. Five studies including 124 PSC patients who received antibiotics were included. Overall, antibiotic treatment was associated with a statistically significant reduction in ALP, MRS, and TSB by 33.2, 36.1, and 28.8%, respectively. ALP reduction was greatest for vancomycin (65.6%, p < 0.002) and smallest with metronidazole (22.7%, p = 0.18). Overall, 8.9% (95% confidence interval: 3.9–13.9) of patients had AEs severe enough to discontinue antibiotic therapy. In PSC patients, antibiotic treatment results in a significant improvement in markers of cholestasis and MRS. Antibiotics, particularly vancomycin, may have a positive effect on PSC either via direct effects on the microbiome or via host-mediated mechanisms.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1055/s-0039-1688501

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 81

Metadata

Authors
Shah, A., Crawford, D., Burger, D., Martin, N., Walker, M., Talley, N. J., Tallis, C., Jones, M., Stuart, K., Keely, S., Lewindon, P., Macdonald, G. A., Morrison, M., & Holtmann, G. J.
Venue
Seminars in Liver Disease
Published
2019-07-17
Volume
39
Issue
04
Pages
432-441
ISSN
  • 0272-8087 (ISSN-L)
  • 1098-8971
OpenAlex
W2961378238
Cited by
81
References
11
FWCI
1.60
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of Antibiotic Therapy in Primary Sclerosing Cholangitis with and without Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. https://app.cochat.ai/papers/10.1055/s-0039-1688501
The paper
Shah, A., Crawford, D., Burger, D., Martin, N., Walker, M., Talley, N. J., Tallis, C., Jones, M., Stuart, K., Keely, S., Lewindon, P., Macdonald, G. A., Morrison, M., & Holtmann, G. J. (2019). Effects of Antibiotic Therapy in Primary Sclerosing Cholangitis with and without Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Seminars in Liver Disease. https://doi.org/10.1055/s-0039-1688501

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.